<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:ccbn="http://www.alacra.com/ccbn" xmlns:newstex="http://www.alacra.com/newstex" ><channel><title>IMS Health Inc. RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>IMS Health Inc.</description>
<link>http://www.alacrastore.com/company-snapshot/IMS_Health_Inc-2001871</link>
<lastBuildDate>Monday, September 08, 2008 1:19:00 PM</lastBuildDate>
<alacra:xlsid>2001871</alacra:xlsid>
<alacra:company>IMS Health Inc.</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><link>http://www.alacrastore.com/storecontent/ccbn/T1937905</link><guid isPermaLink="false">ccbn/T1937905</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Thomas Weisel Partners -  AnalystWe will continue with the program. We are very happy to have IMS Health with us this morning, we have Dave Carlucci, the  Chairman and CEO of the Company, along with Darcie Peck, who has upped the Investor Relations program for the Company. I have asked Dave to give us about five minutes worth of overview and update on the Company. And then we will get into the Q&amp;A session of the program. Dave, welcome and thank you for coming. ...

</description><pubDate>9/4/2008 12:05:57 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">106.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at Thomas Weisel Partners Healthcare Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:10am ET</ccbn:time><title>IMS Health at Thomas Weisel Partners Healthcare Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1937905</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/MCOM-0004-26828372</link><guid isPermaLink="false">newstex/MCOM-0004-26828372</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Jul. ##, #### (M# Communications Ltd. delivered by Newstex) -- IMS Health (NYSE:RX), which provides information, analytics and consulting services to the pharmaceutical and healthcare industries, reported yesterday (## July) its second-quarter...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><pubDate>7/22/2008 7:18:48 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">M2 EquityBites</newstex:Publication><title>Q2 and half year 2008 financial results announced by IMS Health</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">MCOM-0004-26828372</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">IMS HEALTH INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">RX</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1893075</link><guid isPermaLink="false">ccbn/B1893075</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...In consulting and services, particularly in managed markets, pricing and market access and commercial effectiveness practices, growth also accelerated. ...

</description><pubDate>7/21/2008 11:05:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 IMS Health Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00am ET</ccbn:time><title>Q2 2008 IMS Health Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1893075</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1893075</link><guid isPermaLink="false">ccbn/T1893075</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by. Welcome to the IMS Health second quarter #### earnings conference call. During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question and answer session. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded Monday July ##, ####. I would like now to turn the conference over to Darcie Peck, Vice President, Investor Relations. Please go ahead. ...

</description><pubDate>7/21/2008 9:29:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q2 2008 IMS Health Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00am ET</ccbn:time><title>Q2 2008 IMS Health Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1893075</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1814942</link><guid isPermaLink="false">ccbn/T1814942</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Ladies and gentlemen, thank you for standing by. And welcome to IMS Health first quarter #### earnings conference call. During the presentation all participants will be in a listen-only mode, after which we'll conduct a question-and-answer session. (OPERATOR INSTRUCTIONS). As a reminder, this conference is being recorded Thursday, April ##, ####. I'd like now to turn the call over to Darcie Peck, Vice President Investor Relations. Please go ahead. ...

</description><pubDate>7/16/2008 4:55:31 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health, Inc</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 IMS Health Earnings Conference Call</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00AM ET</ccbn:time><title>Q1 2008 IMS Health Earnings Conference Call</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1814942</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1814942</link><guid isPermaLink="false">ccbn/B1814942</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...With significant share of business coming from outside the US, reported growth reflects benefit of weaker dollar....

</description><pubDate>7/16/2008 4:55:26 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health, Inc.</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q1 2008 IMS Health Earnings Conference Call</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00AM ET</ccbn:time><title>Q1 2008 IMS Health Earnings Conference Call</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1814942</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/HUG-0001-26133751</link><guid isPermaLink="false">newstex/HUG-0001-26133751</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> Jun. ##, #### (Hugin AS delivered by Newstex) --   Results announcement for the quarter ended ## March ####  EastPharma (EAST LI), a company active in the manufacturing and marketing of branded generic and in-licensed pharmaceutical...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016048</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04016018</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>6/20/2008 6:15:30 PM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18008000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18004000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18016000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18002000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002007</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002011</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002003</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002013</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002017</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002006</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19001010</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">Hugin AS</newstex:Publication><title>1st Quarter Results</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">HUG-0001-26133751</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">IMS HEALTH INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">RX</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1874869</link><guid isPermaLink="false">ccbn/T1874869</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - William Blair &amp; Company -  AnalystI think we will get started now. Good afternoon, everyone. Our next session is IMS Health. Thank you all for joining us. My name  is John Kreger. I'm the analyst at William Blair that follows IMS and I am required to tell you that William Blair does have an investment banking relationship with the Company. All our other disclosures can be found on our website. I'm thrilled to have David Carlucci back, the CEO of the Company, to present the story. IMS has always been one of our favorite business models with a very high degree of recurring revenue and a great leverageable model. They're also really at the heart of the health care system, which always seems to be a fascinating topic but perhaps more so as we go into the next election cycle. So no shortage of interesting topics to hit on. With that, I'm going to turn the podium over to David to give us an update on what is happening at the Company. ...

</description><pubDate>6/17/2008 4:04:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at William Blair &amp; Company Growth Stock Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">1:40pm CT</ccbn:time><title>IMS Health at William Blair &amp; Company Growth Stock Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1874869</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/newstex/PRN-0005-26013706</link><guid isPermaLink="false">newstex/PRN-0005-26013706</guid><newstex:index_mode xmlns:newstex="http://www.alacra.com/newstex">xml</newstex:index_mode><description> BALTIMORE, Jun. ##, #### (PRNewswire delivered by Newstex) -- Lupin Pharmaceuticals, Inc. (LPI) announced today that it has received tentative approval for the Company's Abbreviated New Drug Application (ANDA) for Escitalopram Oxalate...</description><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04002006</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">04010001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07014012</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">07003001</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13000000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010000</newstex:cat><newstex:cat xmlns:newstex="http://www.alacra.com/newstex">13010005</newstex:cat><pubDate>6/16/2008 11:17:19 AM</pubDate><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18000000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18018000</newstex:event><newstex:event xmlns:newstex="http://www.alacra.com/newstex">18020000</newstex:event><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19000000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002000</newstex:geo><newstex:geo xmlns:newstex="http://www.alacra.com/newstex">19002004</newstex:geo><newstex:Publication xmlns:newstex="http://www.alacra.com/newstex">PR Newswire US</newstex:Publication><title>Lupin Receives USFDA Approval for Escitalopram Oxalate Tablets</title><newstex:docid xmlns:newstex="http://www.alacra.com/newstex">PRN-0005-26013706</newstex:docid><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">FOREST LABORATORIES INC</newstex:index_entry_company><newstex:index_entry_company xmlns:newstex="http://www.alacra.com/newstex">IMS HEALTH INC</newstex:index_entry_company><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">FRX</newstex:index_entry_ticker><newstex:index_entry_ticker xmlns:newstex="http://www.alacra.com/newstex">RX</newstex:index_entry_ticker><category>News</category><alacra:ip>Newstex</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1870407</link><guid isPermaLink="false">ccbn/T1870407</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Goldman Sachs -  AnalystGood afternoon, everybody. For those who don't know me. My name is Randall Stanicky from the generic and supply chain and  [CRO] sectors here at Goldman. And IMS, as you know, is the leader in providing market intelligence to the broader healthcare industry. We are happy to have IMS back again this year, and interesting -- really in a unique position to see an important healthcare trend that we've been highlighting and the shift in growth from the US to the X-US in some of the immerging markets' economies.And interestingly, if you look at the share performance of the US based large pharmaceutical companies and IMS this year, pharma's down, IMS is up, which is an interesting trend and one that the Company has been talking about not being left with some of those declining trends. So, with us to talk about why that is and then also the outlook for some of the growth and the value proposition that IMS has to offer, we're happy to have David Carlucci, who as most of...

</description><pubDate>6/11/2008 12:07:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at Goldman Sachs Healthcare Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">2:40pm PT</ccbn:time><title>IMS Health at Goldman Sachs Healthcare Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1870407</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1859051</link><guid isPermaLink="false">ccbn/T1859051</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - FBR -  AnalystHi, I'm Jim Kumpel from FBR. I'm the healthcare services analyst. We're pleased to have Murray Aitken, who runs the consulting  practice at IMS Health. Also have Darcie Peck from the Investor Relations group to also help out on a number of questions around other parts of the business as well. Murray, if you want to do from here. ...

</description><pubDate>5/28/2008 5:04:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at Friedman Billings Ramsey Capital Markets Spring Investor Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">12:50pm ET</ccbn:time><title>IMS Health at Friedman Billings Ramsey Capital Markets Spring Investor Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1859051</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1816784</link><guid isPermaLink="false">ccbn/T1816784</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Morgan Stanley -  AnalystAlright. #:##. So hello. I am David Veal, the health care services analyst at Morgan Stanley. Before we get started, I have an  announcement. There's been a slight change to the (inaudible) party. It will be held here at the Ritz-Carlton Key Biscayne at The Dune, which is located behind the hotel on the ocean. For guests still interested in going to South Beach, for your convenience, we'll be providing shuttles between the Ritz-Carlton Key Biscayne and the Ritz-Carlton South Beach beginning at #:##, with the last shuttle returning to Ritz-Carlton Key Biscayne at ## p.m. So no party at -- don't go to the Raleigh. Stay here. Shuttles to South Beach starting at #:##, coming back at ##. Revised shuttle schedules are available at the conference registration desk. So for all the partiers out there, do take note. So without further adieu, we have IMS Health. Leslye Katz, CFO, and Darcie Peck, IR Dude, as she says. Thank you for coming and we appreciate you being here....

</description><pubDate>5/2/2008 12:06:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">3:00pm ET</ccbn:time><title>IMS Health at Morgan Stanley 2008 Global Healthcare Unplugged Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1816784</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1797473</link><guid isPermaLink="false">ccbn/T1797473</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - Lehman Brothers -  AnalystOkay, good morning. Larry Marsh again. Delighted to have with us IMS Health back again this year and we're certainly delighted  to have David Carlucci with us, Chairman and CEO as well as Darcie Peck. Most of you know IMS is really the leading market intelligence provider to the pharmaceutical and other parts of the healthcare industry and has really been proactive of late in dealing with some of the challenges of its customers that it has talked about and as we've all heard about in the global environment. I was just talking to David about some of the actions that they have taken and the reaction of the marketplace which I think the reaction has certainly been forward thinking. So with that, let me turn it over to David and Darcie to talk to us about IMS and the actions they've taken and some of the outlook that they see for ####. David? Delighted to have you with us. ...

</description><pubDate>3/19/2008 12:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at Lehman Brothers Healthcare Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">9:30am ET</ccbn:time><title>IMS Health at Lehman Brothers Healthcare Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1797473</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/304457</link><guid isPermaLink="false">bir/304457</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>IMS Health Inc.</title><bir:company xmlns:bir="http://www.alacra.com/bir">IMS Health Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">I.M.S. International Inc.</bir:company><bir:company xmlns:bir="http://www.alacra.com/bir">Data Niche Associates Inc.</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">United States</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Services: Developer of information solutions and market research for the health care industry.</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">7374</bir:sic><bir:ssic xmlns:bir="http://www.alacra.com/bir">8732</bir:ssic><bir:ssic xmlns:bir="http://www.alacra.com/bir">7372</bir:ssic><bir:naics xmlns:bir="http://www.alacra.com/bir">518210</bir:naics><bir:snaics xmlns:bir="http://www.alacra.com/bir">511210</bir:snaics><bir:snaics xmlns:bir="http://www.alacra.com/bir">541910</bir:snaics><bir:class xmlns:bir="http://www.alacra.com/bir">2</bir:class><bir:class xmlns:bir="http://www.alacra.com/bir">4</bir:class><bir:class xmlns:bir="http://www.alacra.com/bir">17</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">H</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">K</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">RX</bir:ticker><pubDate>3/15/2008 6:17:00 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">304457</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1791707</link><guid isPermaLink="false">ccbn/T1791707</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>...Great. Yeah, we'll stay on schedule I believe and I think this is the next presentation before the lunch. And, wait a second. So good morning. My name is Steve Unger. I'm also the pharmaceutical services analyst here at Bear Stearns. The next company presenting is IMS Health. And IMS, if you didn't know, has been under my coverage, this will be the tenth year now that I've covered this company and I've definitely seen significant changes within the company over the years and as the drug industry itself has changed. With us today is first time presenting I believe, not IMS but for her, is the senior vice president and chief financial officer, Leslye Katz, who has served many financial roles at IMS over the last few years including most recently being the corporate controller prior to her finally, her CFO appointment early last year. And Leslye is here to provide an overview of the company and then answer your questions in the remaining time. I will--I do have one required disclosure to make...

</description><pubDate>3/13/2008 12:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at Bear, Stearns &amp; Co. Inc.  London Healthcare Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">11:45am UKT</ccbn:time><title>IMS Health at Bear, Stearns &amp; Co. Inc.  London Healthcare Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1791707</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1782437</link><guid isPermaLink="false">ccbn/T1782437</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>... - IMS Health, Inc. -  SVP and CFO First, I will give you a brief overview of our Company and of our expanded market opportunity, then I will recap our ####  performance, including the dynamics behind the restructuring plans that we put in place in the fourth quarter of '##, and finally I will cover our outlook for #### and the specific programs we have underway both in terms of revenue and cost and expense to deliver on our #### guidance. So, let me start with a brief overview of IMS. As you may know, we serve a diverse customer set within the healthcare industry and we provide information, analytics, consulting and services to help our clients become more competitive and productive around the globe. We've been a leader in this industry for more than ## years. We have extensive global information assets, substantial technology underpinning those assets and we have a significant portfolio of patents in place to protect our intellectual property. So, that represents some very significant...

</description><pubDate>3/4/2008 6:04:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health at Raymond James Annual Institutional Investor Conference Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">2:50pm ET</ccbn:time><title>IMS Health at Raymond James Annual Institutional Investor Conference Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1782437</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1747512</link><guid isPermaLink="false">ccbn/B1747512</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>Q# #### IMS Health Earnings Conference Call</description><pubDate>1/31/2008 12:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 IMS Health Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00am ET</ccbn:time><title>Q4 2007 IMS Health Earnings Conference Call Summary</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1747512</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1747512</link><guid isPermaLink="false">ccbn/T1747512</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><description>Q# #### IMS Health Earnings Conference Call</description><pubDate>1/31/2008 10:06:00 AM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q4 2007 IMS Health Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">8:00am ET</ccbn:time><title>Q4 2007 IMS Health Earnings Conference Call Transcript</title><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1747512</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/B1659152</link><guid isPermaLink="false">ccbn/B1659152</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>10/17/2007 10:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Edited</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q3 2007 IMS Health Earnings Conference Call Summary</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">5:00pm ET</ccbn:time><title>Q3 2007 IMS Health Earnings Conference Call Summary</title><description>...After ten straight quarters of double-digit growth through #Q##, Co. is now seeing moderating growth that reflects intensifying challenges clients face in several countries. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Brief</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">B1659152</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/ccbn/T1659152</link><guid isPermaLink="false">ccbn/T1659152</guid><ccbn:index_mode xmlns:ccbn="http://www.alacra.com/ccbn">norm</ccbn:index_mode><pubDate>10/17/2007 7:06:00 PM</pubDate><ccbn:name xmlns:ccbn="http://www.alacra.com/ccbn">IMS Health</ccbn:name><ccbn:price xmlns:ccbn="http://www.alacra.com/ccbn">54.0000</ccbn:price><ccbn:revision xmlns:ccbn="http://www.alacra.com/ccbn">Final</ccbn:revision><ccbn:storetitle xmlns:ccbn="http://www.alacra.com/ccbn">Q3 2007 IMS Health Earnings Conference Call Transcript</ccbn:storetitle><ccbn:ticker xmlns:ccbn="http://www.alacra.com/ccbn">RX</ccbn:ticker><ccbn:time xmlns:ccbn="http://www.alacra.com/ccbn">5:00pm ET</ccbn:time><title>Q3 2007 IMS Health Earnings Conference Call Transcript</title><description>...Good afternoon, ladies and gentlemen. Thank you for standing by, and welcome to the IMS Health third quarter #### earnings conference call. During the presentation all participants will be in a listen-only mode. Afterwards we will conduct a question-and-answer session. (OPERATOR INSTRUCTIONS) As a reminder, this conference is being recorded Wednesday, October ##, ####. I would now like to turn the conference over to Darcie Peck, Vice President, Investor Relations. Please go ahead. ...

</description><ccbn:type xmlns:ccbn="http://www.alacra.com/ccbn">Transcript</ccbn:type><ccbn:docid xmlns:ccbn="http://www.alacra.com/ccbn">T1659152</ccbn:docid><category>Credit &amp; Investment Research</category><alacra:ip>Thomson Street Events</alacra:ip></item></channel></rss>